California residents 65 and older now qualify for COVID-19 vaccinations. Questions about the mRNA Covid-19 vaccines still remain. Vaccine expert Dr. David Lo, a distinguished professor of biomedical sciences and senior associate dean for research in the School of Medicine at the University of California, Riverside, answers several questions in...
A UC Riverside-led study, funded by Merck, is set to find out
Open-source code developed at UC Riverside is free, versatile, and easy to use
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
Host campus UC Riverside will be joined by UC Davis and UC Merced
Meeting virtually with people outside your household is safest, says UC Riverside epidemiologist
UC Riverside study focused on how HIV mutates to escape the immune system
More than half of American adults with advanced multiple sclerosis report mistreatment by caregivers
UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
Policy has limited impact on vaccine uptake because of individual decision making, study finds
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
UC Riverside-led team’s technique relied on determining the mass of galaxy clusters
UC Riverside psychologist Chandra Reynolds will lead the five-year research project
A new theory about the nature of dark matter helps explain why a pair of galaxies about 65 million light-years from Earth contains very little of the mysterious matter, according to a study led by a physicist at the University of California, Riverside. Dark matter is nonluminous and cannot be...
UC Riverside mouse study focused on neurons in the hippocampus